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 This paper looks at the history of current United Kingdom dietary guidelines for the 
prevention of heart disease and evaluates available evidence to support the 
relationship between saturated fat and coronary heart disease and recommendations 
to replace energy from a reduction in saturated and total fat intake with carbohydrate. 
Results show a lack of support for a reduced fat diet with replacement of energy with 
carbohydrate. The relationship between saturated fat, total fat and heart disease is 
inconsistent across studies with evidence pertaining to the UK weak. Further 
investigation into the relationship is recommended.   
Introduction  
Cardiovascular disease (CVD) the collective term for diseases of the heart and blood 
vessels was responsible for 161,252 deaths in the United Kingdom (UK) in 2012 
(Townsend, Williams, Bhatnagar, Wickramasinghe, & Rayner, 2014). CVD mortality has 
been declining and for the first time since 1961 is no longer the overall leading cause 
of death in the UK (Townsend, Williams, Bhatnagar, Wickramasinghe, & Rayner, 2014). 
UK Dietary Guidelines For The Prevention Of 
Cardiovascular Disease. 
Literature Review of available evidence and if it supports current dietary 
guidelines to reduce Total and Saturated Fat. 
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Coronary heart disease (CHD) accounts for 48% of CVD deaths and remains the largest 
single cause of death accounting for 73,680 deaths in the UK in 2012 (Townsend, 
Williams, Bhatnagar, Wickramasinghe, & Rayner, 2014). CHD presents as myocardial 
infarction (MI), angina, silent ischemia, unstable angina, arrhythmias, heart failure and 
sudden death, with the  most common cause  a build-up of atheroma leading to  
narrowing of vessels and occlusions (Grech, 2003).  The estimated cost of CVD to the 
UK economy was an estimated €18.9 billion in 2014 (Centre for Economics and 
Business Research, 2014). 
Smoking, diabetes, hyperlipidaemia and hypertension are known conventional risk 
factors (Khot, et al., 2003). In addition to conventional risk factors the INTERHEART 
study identified abdominal obesity, psychosocial stress, fruit and vegetable intake, 
physical activity and alcohol consumption, with the nine factors  accounting for 90% of 
CHD risk (Yusef, et al., 2004).  
In recent years a number of reviews and meta-analysis have called into question the 
relationship between Saturated fat (SFA) and CVD (Chowdhury, et al., 2014) (Ramsden, 
et al., 2013) (Siri-Tarini, Sun, Hu, & Krauss, 2010). It has been suggested by Harcombe 
et al (2015) that prior to UK dietary guidelines becoming policy evidence from RCTs 
was lacking, with the authors suggesting dietary guidelines should never have been 
introduced. The aim of this review is to look at the history of the guidelines and the 




History of Dietary Guidelines in the UK  
The first Committee on Medical Aspects of Food Policy (COMA) panel on diet and heart 
disease was formed in 1970 in response to the 1969 meeting called to discuss the 
findings of Strom & Jensen (1951) on the effect of diet on CHD  (Morgan, 2012) (Bufton 
M. , 2005) .  
The panel took three years and ten drafts to produce their report having considered 
over 400 papers (DHSS, 1974). The report’s recommendations listed in Table 1 were 
basic with advice to reduce intake of sugar and fat, particularly saturated fat. The basic 
advice was a result of the panel unable to reach a consensus, expressed by Professor 
John Yudkin, stating that the report had exaggerated the possible role of dietary fat in 
causing CHD and had minimised the possible role of dietary sucrose. Due to the lack of 
consensus the recommendations were not made policy (Bufton M. , 2001). 
In 1984 the second COMA report was published having considered over 600 scientific 
papers and 40 working papers however consensus again was not reached (DHSS, 
1984). The objecting member Professor Mitchell strongly disagreed with the assertion 
that there was a causal link between SFA and risk of heart disease (Bufton & Berridge, 
2000). Despite lack of consensus the guidelines, listed in Table 1 issued quantitative 
dietary recommendations.   
 It was suggested by the Vice chairman of the National Advisory Committee on 
Nutrition Education (NACNE) that the 1984 COMA report was created to provide a 
mechanism for Government to distance themselves from the NACNE 1983 quasi-
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official policy proposals, suggesting COMA felt under pressure to produce a report that 
would be acceptable to Government (Bufton & Berridge, 2000).  
The most recent COMA report on diet and heart disease was published in 1994 with no 
reported dissenters on the panel (DOH, 1994). In 2000 COMA was disbanded and 
replaced by the Scientific Advisory Committee on Nutrition (SACN) (DOH, 2012). 
Current dietary guidelines listed in Table 1 are based on the 1994 COMA report. 
Table 1: Summary of Dietary Guidelines 
 1974 (DHSS, 1974) 1984 (DHSS, 1984) 1994 (DOH, 1994) 
Total Fat Reduce Intake 35% 35% 
Saturated Fat Reduce intake 15% No more than 10% 
n-6 Polyunsaturated No increase No specific 
recommendation 
No increase in average 
intakes with those 
consuming >10% TE no 
further increase. 
n-3 polyunsaturated No increase No specific 
recommendation 
Increase to 0.2g / day 






evidence for LDL 
reduction is inconsistent 
Trans fatty acids No 
recommendation 
Treated same as SFA 
but no specific 
recommendations. 
No more than 2% with 
consideration to reduce 
intake 
Sugar Reduce intake No increased intake No specific advice but 
COMA Panel on DRV 
recommended no more 





Panel sees advantage 
in replacing calories 
from reduced fat with 
fibre rich CHO but no 
specific 
recommendation.  
Complex CHO and 
sugars in fruits and 
vegetables should 
restore energy deficit 
from reduction in fat. 
Recommended increase 





Evidence Base for Dietary Guidelines 
None of the published COMA reports contain references of the papers considered in 
the creation of their respective guidelines thus it is not possible to critique the exact 
literature used. No working papers were found.  
Review of the literature 
Intervention Trials  
Primary Prevention 
The non-randomised Finnish Mental Hospital study was the only exclusively primary 
prevention trial found. The study reported a significantly lower CHD mortality in the 
experimental modified fat diet in men but not women (Turpeinen, et al., 1979) 
(Meittinen, et al., 1983). The disproportionate use of the cardio-toxic drug thioridazine 
in one of the study arms (Ramsden, Hibbeln, Majchrzak, & Davis, 2010) and the 
inappropriate crossover study design to test CHD, a progressive disease, may have 
confounded results.  
Two Randomised control trials (RCT) tested a fat modified diet using oil filled products 
to increase PUFA consumption while decreasing SFA intake contained subjects with or 
without existing CHD (Dayton, Pearce, Hashimoto, Dixon, & Tomiyasu, 1969), (Frantz, 
et al., 1989). 
In the double blinded Minnesota Coronary Survey no significant differences in primary 
endpoints of CVD mortality or events in either men or women were reported (Frantz, 
et al., 1989). Similarly the partially blinded male only LA Veterans trial found no 
significant difference between experimental and control groups in either the CHD 
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events of sudden death or MI were found. There was however a significant difference 
when results were pooled with secondary CVD event endpoints (Dayton, Pearce, 
Hashimoto, Dixon, & Tomiyasu, 1969).  
All trials lowered total serum cholesterol levels (TC) in the treatment arms. However 
there was no effect on total mortality in the Finnish hospital study or LA Veterans trial, 
which reported higher all-cause mortality in the experimental group. In both of these 
studies adherence was poor with only half of meals available consumed onsite in the 
LA Veterans trial. Food eaten off site was considered but not analysed in the same 
manner. In the Finnish Mental Hospital study only 33% of women and 53% of men 
were present for the entire study period with meals eaten outside the hospital not 
accounted for.  
No primary prevention trials were found to have tested a reduced fat diet. A summary 
of the all studies included this review can be found in the appendix. 
Secondary Prevention Trials 
Four RCTs and one non randomised trial were found which focused on fat modification 
and one RCT on fat reduction. All studies were of men and not women. Three studies 
identified were UK based (Rose, Thomson, & Williams, 1965) (Ball, et al., 1965) (MRC, 
1968).  
The Oslo diet-heart study reported a positive association between CHD and lowering 
SFA, however only CHD relapses and nonfatal MIs were reduced, there was no 
difference in overall CHD mortality after eleven years of follow up (Leren, 1970). While 
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this was the longest running study at 11 years no dietary analysis was completed after 
five years.  
The non-randomised study on young males aged 30-50 (Bierendaum, et al., 1970) 
reported a lower rate of reinfarctions in the experimental group however the study 
had many design  issues.  After one year due to a lack of difference between 
experimental groups the researchers assumed a lack of compliance so issued frozen 
meals, however after another six months no difference remained so a control group 
was added and the two diet groups merged. The control group contained more heavy 
smokers and more heavy drinkers than the experimental group. In the experimental 
group the overweight men were put on a calorie control diet, however those in the 
control were not. The study is the only one to test only younger men when the 
incidence rate of CHD is lower than older men and given the small sample size 
significant findings were unlikely.  
Reanalysis of data from Woodhill and colleagues Sydney Diet Heart study data 
reported higher incidence of CHD and CVD mortality in the intervention than control 
(Woodhill, Palmer, Leelarthaepin, McGilchrist, & Blacket, 1978) (Ramsden, et al., 
2013), likewise the corn oil trial found more of the control group remained free of 
cardiac events than either intervention (Rose, Thomson, & Williams, 1965).  
A single trial was identified to have tested the effect of fat reduction and reported no 
significant difference in coronary relapses or deaths (Ball, et al., 1965) . Like 
Bierenbaum et al the overweight were put on a weight loss diet with 21% of the 
control group and 15% of the intervention on a reduced calorie intake. This may have 
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confounded the results with any effect possibly attributable to weight loss rather than 
diet.  
All studies reported lowered TC in the intervention group however the Corn oil study 
despite a significant reduction in the first 18 months reported a non-significant change 
from baseline at study end. The Oslo trial found while TC was higher in those who 
relapsed with only a difference in groups in men under 60 (Leren, 1970). The MRC Soya 
trial reported relapses were not related to initial cholesterol level (MRC, 1968). 
In all studies total mortality was not reduced in the intervention groups with both the 
low fat and Sydney trial reporting higher all-cause mortality in intervention groups 
than control (Ball, et al., 1965) (Ramsden, et al., 2013). 
The efficacy of secondary prevention trials to test the effect of TF and SFA on CHD has 
been questioned with men having suffered an MI likely to make multiple lifestyle 
changes which may confound findings (Woodhill, Palmer, Leelarthaepin, McGilchrist, & 
Blacket, 1978).  
Observational Studies 
Twenty two observational studies were found which included clear data on SFA intake 
and CHD of which four were of UK participants (Fehily, Yarnell, Sweetnam, & Elwood, 
1993), (Mann, Appleby, Key, & Thorogood, 1997), (Boniface & Tefft, 2002), (Morris, 
Marr, & Clayton, 1977).  
Two studies reported a clear positive association between SFA and CHD, Mann, 
Appleby, Key, & Thorogood (1997) reported a positive relationship between saturated 
animal fat and CHD mortality (P<0.01) in health conscious individuals. Kromhout et al 
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(1995) reported a significant (P<0.001) association between SFA with 25 year CHD 
mortality rate in sixteen cohorts of the Seven Countries study. Although two of the 
rural Italian cohorts included were analysed by Farchi et al (1989) who reported a 
significant inverse relationship between SFA and CHD (P<0.01).   
The Seven Countries study, a 10 year investigation led by Ancel Keys of men aged 40-
59 from sixteen cohorts researched CHD in six western countries and Japan. No 
rationale was given for the countries selected apart from opportunity and practicality 
with friendships and personal contacts influencing cohort locations (Keys A. , 1980). 
Keys found median TC strongly related to CHD mortality (r=0.80) but not all cause 
mortality, with low TC correlated with non CHD deaths. In men without CVD at entry 
total fat intake (r=0.50) and SFA intake (r=0.84) was correlated with CHD mortality, 
although intakes varied largely between cohorts.  
The study had a number of limitations, the American Railroad cohort, the studies 
largest, failed to reach follow up due to funding issues and the Rome railroad men’s 
final examinations were incomplete which may have affected results.  
The lowest CHD mortality reported in Crete and attributed to their dietary habits did 
not take into account the Greek Orthodox church practice of regular fasting with  60% 
of the cohort following all fasting periods of the church (Cannon, 2004), (Katerina & 
Kafatos, 2005).   
Ten studies reported no relationship between SFA and CHD (Shekelle, et al., 1981) 
(Fehily, Yarnell, Sweetnam, & Elwood, 1993), (Pietinen, et al., 1997) (Leosdottir, 
Nilsson, Nilsson, & Berglund, 2007) (Knekt, et al., 1994) (Kromhout & De Coulander, 
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1984) (Garcia-Palmieri, et al., 1980) (Morris, Marr, & Clayton, 1977) (Tucker, et al., 
2005) (Farchi, et al., 1989). 
McGee et al reported a significant association (P<0.05) with relative (%TE) SFA intake 
and CHD but not absolute intake (g) (McGee, Reed, Yano, Kagan, & Tillotson, 1984) , 
similarly Posner et al found no association overall but when adjusted for energy intake 
%TE SFA in men aged 45-56 was significantly (P<0.050) related (Posner, et al., 1991).  
Two of seven studies which included both men and women reported positive 
associations in women but not men (Jakobsen, Overvad, Dyerberg, Schroll, & 
Heitmann, 2004) (Boniface & Tefft, 2002), with the latter reporting a significant 
relationship in only women aged 60-75 (P<0.01). CVD in females is known to develop 
seven to ten years later than in men which may have affected results (Maas & 
Appelman, 2010).  Significant findings in two other studies were affected by age, 
regardless of gender, Esrey, Joseph, & Grover (1996) only reported a positive 
association in those aged 30-59 (P<0.01) and Xu et al (2006) only in those aged 47-59. 
Multivariate analysis removed significance from three studies reporting a positive 
trend between SFA with CHD (Oh, Hu, Manson, Stampfer, & Willett, 2005) (Ascherio, 
et al., 1996) (Yamagishi, et al., 2010). Conversely Kushi et al found %TE SFA to be 
associated with twenty year CHD mortality (P<0.005) only after multivariate analysis,  
despite a non-significant 0.5% difference in SFA %TE intake between men who died of 
CHD or those without CHD (Kushi, et al., 1985).  
Tucker et al (2005) found a low intake of SFA was not protective of CHD incidence 
(P<0.005) although each gram of SFA was related to a 7% increased risk of death from 
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CHD (P<0.001), however SFA intake was grouped with low fruit and vegetable which 
may have confounded results. 
Dietary Reporting 
Studies varied in reporting methods with dietary intake being split into subgroups, 
either by SFA intake or via disease status in the majority with a few such as the 
Shekelle et al (1981) only reporting the cohorts mean diet.  
Dietary SFA intake reported as relative %TE rather than absolute g/day in the Honolulu 
and Framingham Study affected whether the association with CHD was significant or 
not (McGee, Reed, Yano, Kagan, & Tillotson, 1984) (Posner, et al., 1991). Posing the 
question of whether the absolute or relative contribution of SFA or TF that has the 
greater impact. If SFA were to have a linear dose response, then a greater absolute 
intake would have a greater impact on disease risk than the relative intake which is 
influenced by either total energy intake or other dietary macronutrients, unless the 
influence of SFA intake is interrelated and mitigated by other dietary factors suggested 
by the fruit and vegetable or fibre intake in the Baltimore study (Tucker, et al., 2005).  
Intake of SFA varied across cohorts from 9.2g in Japan (Yamagishi et al 2010) to 78g in 
Finland (Knekt et al 1994), with the latter reporting no association between SFA and 
CHD. The high intakes of SFA reported by Knekt et al stand as an outlier with men free 
from CHD after a 14 year follow up consuming 73g SFA compared to the 78g consumed 
by men who died of CHD. This may be explained by geographical differences, a non-
linear effect of SFA or an unidentified confounder. 
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Five of twenty two observational studies identified reported a lower energy intake in 
those with CHD with Boniface & Tefft (2002) suggesting total energy may cause a non-
random error. In addition to Boniface & Tefft (2002) lower energy intakes in those with 
CHD were also reported in the Ireland-Boston Diet-Heart trial (Kushi, et al., 1985), 
Caerphilly (Fehily, Yarnell, Sweetnam, & Elwood, 1993), Lipid Research Clinics (Esrey, 
Joseph, & Grover, 1996) and Zutphen studies (Kromhout & De Coulander, 1984).   
Methods of recording dietary intake used in the cohort studies raise questions of how 
well a 24 hour recall , food frequency questionnaire (FFQ) or 7 day diary represents not 
only the habits of the previous year but also an individual’s long term intake when in 
certain studies up to and over twenty years pass between dietary assessment and 
study end.  
While simple to administer in large scale studies the FFQ has been shown to 
underreport energy intake and is a poor predictor of both relative and absolute 
macronutrient intakes (Paul, Rhodes, Kramer, Baer, & Rumpler, 2005). It has also been 
suggested that the use of FFQ may mask associations, in a pooled analysis of cohort 
studies a significant relationship between breast cancer and dietary SFA was reported 
in a seven day food diary intake but not a FFQ (Bingham, et al., 2003). Ten studies of 
the twenty two were based on a FFQ, three of which validated intake either by 
interview (Shekelle, et al., 1981), seven day food diary (Leosdottir, Nilsson, Nilsson, & 
Berglund, 2007) or weighed food diary (Fehily, Yarnell, Sweetnam, & Elwood, 1993).  
Five studies assessed diet using a twenty four hour recall (McGee, Reed, Yano, Kagan, 
& Tillotson, 1984), (Posner, et al., 1991), (Esrey, Joseph, & Grover, 1996), (Xu, et al., 
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2006), (Garcia-Palmieri, et al., 1980). Twenty four hour recall has shown similar validity 
to FFQ with the 7 day diary closest to a weighed dietary record (Bingham, et al., 1997). 
While it is possible the use of FFQ and twenty four hour recall may have masked 
findings only four studies using FFQ and one using 24hr recall reported no association 
between SFA and CHD (Shekelle, et al., 1981) (Fehily, Yarnell, Sweetnam, & Elwood, 
1993) (Ascherio, et al., 1996) (Pietinen, et al., 1997) (Garcia-Palmieri, et al., 1980). The 
lack influence of dietary assessment method and its impact on findings is further 
questioned by two of four studies using weighed dietary intakes reporting no 
association between SFA and CHD (Fehily, Yarnell, Sweetnam, & Elwood, 1993) 
(Morris, Marr, & Clayton, 1977) with Jakobsen, Overvad, Dyerberg, Schroll, & 
Heitmann (2004) only reporting an association in women.  
Only five of twenty two observational studies identified followed up on dietary intake. 
Shekelle, et al (1981) followed up after one year during a twenty year observation 
period whereas Oh, Hu, Manson, Stampfer, & Willett (2005) assessed diet five times in 
the same period. Tucker, et al (2005) followed up diet four times in eighteen years and 
Knekt, et al (1994) twice in fourteen years. In the Seven Countries study repeated 
dietary surveys were completed but in only seven of sixteen cohorts (Kromhout, et al., 
1995).  
Geographical Differences 
A study of Japanese living in Hawaii, America and Japan found TC to be higher in 
America compared to those in Japan despite eating equivalent diets suggesting 
another factor other than dietary fat. Japanese-Americans who retained a traditional 
way of life had CHD prevalence as low as observed in Japan suggesting cultural rather 
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than dietary differences. Those who adopted an American way of life but maintained a 
traditional Japanese diet had a higher prevalence of CHD than those who had retained 
traditional culture but adopted an American high fat diet (Marmot & Syme, 1976).  
The findings of Marmot & Syme may explain the geographical differences in the study 
of Irish men, with the men living in Ireland suffering a lower CHD mortality rate than 
those in Boston, USA despite consuming more SFA as %TE (Kushi et al, 1985). 
Reviews and Meta-Analysis  
Seven review papers found looked at evidence of dietary fat on CHD, one addressed 
SFA specifically (Siri-Tarini, Sun, Hu, & Krauss, 2010). Summary of Review findings, 
inclusion criteria and included papers are listed in the appendix. 
Siri-Tarini et al concluded no significant evidence for supporting the association between SFA 
and risk of CHD in observational studies (Siri-Tarini, Sun, Hu, & Krauss, 2010), although the 
papers statistical analysis and methodology have been questioned (Stamler, 2010) 
(Scarborough, Rayner, van Dis, & Norum, 2010) (Katan & Brouwer, 2010).  
Similarly Chowdhury et al (2014) who concluded current evidence does not support advice to 
lower SFA intake and increase PUFA intake received similar criticism (Willett, Stampfer, & 
Sacks, 2014). The findings of Chowdhury et al are supported by Ramsden et al (2013).  
Conversely Mozaffarian et al reported an overall risk reduction of 19% corresponding 
to 10% reduction in CHD risk per 5% energy replacement of SFA with PUFA 
(Mozaffarian, Micha, & Wallace, 2010). Study duration was a significant (P<0.017) 
factor in risk reduction with longer studies showing greater benefits. 
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The World Health Organisation (WHO) expert consultation report on fats and fatty 
acids in Human Nutrition (FAO, 2010) was based on the review by Jakobsen et al 
(2009) and meta-analysis by Skeaff and Miller (2009). Jakobsen et al concluded 
reducing and replacing SFA with PUFA prevents CHD while Skeaff and Miller concluded 
available evidence was unsatisfactory.  
The Cochrane review on Reduced or modified dietary fat for preventing CVD reported 
a 14% reduced risk of combined CVD events in any type of dietary fat intervention 
compared to a control diet (P<0.007) (Hooper, et al., 2012). However the relationship 
to specific CVD events e.g. MI was not significant. When studies with systematic 
differences in care between intervention and control groups were removed along with 
studies with multiple dietary interventions other than just dietary fat then the risk 
reduction was no longer statistically significant. Differences between subgroups were 
also non-significant with no difference between modified, reduced or modified and 
reduced fat trials, all of which individually had no significant relationship with CVD 
events. Subgrouping results showed combined risk reduction was attributable to 
modified fat and modified reduced fat studies of at least two years and only in men 
with a moderate to high risk at baseline, not general population groups. There was no 
relationship of dietary fat with either total or CVD mortality.  
Serum Cholesterol and CHD 
The current guidelines recommend a reduction of SFA intake based on the association 
between SFA and both TC and low density lipoprotein (LDL) cholesterol levels (DOH, 
1994). European guidelines suggest a target TC level <5mmol/L and LDL <3mmol/L in 
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healthy adults (Perk, et al., 2012). There is no official UK target for cholesterol levels 
(NICE, 2014).  
Metabolic ward studies have demonstrated dietary SFA increases serum cholesterol 
levels (Keys, Anderson, & Grande, 1957) (Hegsted, McGandy, Myers, & Stare, 1965) 
however SFA intake also increases HDL levels so the HDL to TC ratio remains unaltered 
(Siri-Tarino P. W., Sun, Hu, & Krauss, 2010).  
A number of studies discussed below challenge the association between TC, LDL and 
CHD as well as the desirability of achieving a low TC level. The World Health 
Organisation (WHO) Multinational Monitoring of Trends and Determinants in 
Cardiovascular Disease (MONICA) set up in to investigate and explain the decline in 
CHD mortality seen in the 1960’s (Kuulasmaa, et al., 2000) failed to report a significant 
effect of cholesterol on CVD mortality (WHO, 1994). 
Results from two studies on CHD hospitalisations observed raised cholesterol in only 
the minority of cases. Canto et al (2011) reported only 28% of patients hospitalised 
between 1994 and 2006 with their first MI presented with dyslipidaemia while 
Sachdeva et al (2009) reported an average admission TC level of 174.4mg/dl 
(4.5mmol/L), with 56.4% of patients LDL levels < 100mg/dl. (2.6mmol/L). In those 
without prior CHD or diabetes 72.1% had admission LDL <130 mg/dL (3.4mmol/L) and 
41.5% <100 mg/dL (2.6mmol/l). However the authors note lipid levels post MI may not 
be representative of baseline due to the acute phase response (Sachdeva, et al., 2009). 
Observational studies have also questioned the orthodoxy of the cholesterol CHD 
relationship. The 30 year follow up of the Framingham study found an inverse 
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relationship between cholesterol levels and an increased risk of CHD and total 
mortality. For every 1mg drop in cholesterol levels there was an 11% increase in 
coronary and total mortality (Anderson, Castelli, & Levy, 1987). Castelli noted those 
with higher SFA and energy intakes had lower TC levels (Castelli, 1992).  
The Honolulu Heart Program of 3572 Japanese-American men aged 71-93 years found 
only a significant relationship with mortality in those who had low serum cholesterol 
levels at entry and exit  (Schatz et al., 2001). Similar findings were reported by Nago et 
al (2011) noting a clear relationship in Japanese men and women between low TC and 
increased mortality, with the highest CHD mortality incidence in men with a TC below 
4.4mmol/L (Nago, Ishikawa, Goto, & Kayaba, 2011). 
In Danish men and women significantly lower all-cause mortality was reported in those 
with TC levels 5-7.99mmol/L compared to those with TC below 5mmol/L (P<0.001). 
Participants aged over 50, free of diabetes, CVD and statin use at baseline reported 
higher than recommended LDL levels (>2.5mmol/L) were similarly significantly 
protective. Increased Triglyceride levels were linked with increased risk of CHD, 
particularly in women suggesting guidelines should focus on triglyceride levers rather 
than lipid levels (Bathum et al., 2013).  
Results from a meta-analysis of 61 prospective studies covering 11.6 million person-
years at risk in men and women aged 40-89 found a weak positive association between 
TC and CHD mortality in only those aged 40-69 (Prospective Studies Collaboration, 
2007). The association however was significant in those aged 70-79 (P0.04) and 80-89 
(P0.0005) contrasting with the findings of both Nago et al (2011) and Schatz et al 
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(2001). Such findings may be explained by the work of Petursson et al (2012) who 
suggest cholesterol may act differently as a risk factor for CHD than previously believed 
with the authors observing a u-shaped curve between TC and CVD in both men and 
women (Petursson, et al., 2012).  
Carbohydrate and CHD 
Current guidelines recommend the energy deficit from a reduced fat intake be made 
up with complex carbohydrate (CHO) and sugars in fruit and vegetables (DOH, 1994).   
This advice may have unintended consequences, the 2000 United States (US) dietary 
guidelines committee noted their advice to increase CHO consumption had 
corresponded with increasing rates of obesity (Hite et al., 2010).  
Only one RCT testing a low fat high CHO diet was identified, reporting no effect on CHD 
(Ball, et al., 1965).  Kuipers et al (2011) suggest a shift in focus from reducing SFA to 
reducing CHO, particularly high glycaemic (GI) sources as it is shown that a high CHO 
diet can increase risk of cardiovascular disease (Kuipers et al 2011) with postprandial 
hyperglycaemia induced by high GI foods suggested to increase CVD risk through 
oxidative stress (Ludwig, 2002).  
A study recording none fasting glucose levels found elevated blood glucose may be 
causally related to development of CHD (Benn et al., 2012). This is supported by Khaw 
et al who reported a significantly (P<0.001) increased risk of CHD with increased levels 
of Haemoglobin A1c (Hba1c), an indicator of average blood glucose concentration over 
the preceding months. In those without diabetes or history of CHD there was a relative 
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risk (P<0.002) of 1.4 for every 1% increase in HbA1c (Khaw, et al., 2004). Both studies 
findings were independent of diabetes status.  
Studies of UK Dietary Guidelines  
One RCT testing UK Dietary guidelines was identified, predicting the adherence to 
recommendations could reduce the risk of fatal CVD by 15% and nonfatal CVD by 30% 
(Reidlinger, et al., 2015). Those given advice to follow dietary guidelines reported a 
drop in all lipid levels compared to baseline, with a significant drop in TC and LDL 
compared to control.  The study however had a number of issues; the studies twelve 
week duration with no CVD endpoints do not show the long term efficacy of the diet. 
Furthermore comparison with the studies control group is questionable with the group 
given dietary advice to follow a traditional British diet along with supplemental foods 
with no rationale for the traditional British diet advice given.  Weight loss in the dietary 
guideline group (1.3KG) and with weight gain (0.6KG) in the control group along with 
an unequal gender spilt may have also confounded results.  
Conclusion 
From the evidence considered in this review it is clear there is no consistent link 
between SFA and CHD although it is clear in certain populations and demographics an 
association exists. The lack of a consistent association is not however evidence that no 
relationship exists. Harcombe et al (2015) noted that prior to UK dietary guidelines 




Since the publication of 1994 guidelines no primary or secondary prevention RCTs on 
SFA and CHD were found to have been completed. Twelve of twenty two cohort 
studies identified in this review were completed or had findings published after 1994 
with only two reporting a clear association, both with issues discussed in this paper 
(Mann, Appleby, Key, & Thorogood, 1997) (Kromhout, et al., 1995). No clinical trials of 
decreased SFA intake and CHD were identified, the 1984 COMA panel noted due to 
cost such a trial would unlikely to ever be completed (DHSS, 1984).   
Limitations of dietary intervention trials may have confounded results. To test the 
effect of SFA requires the modulation of other nutrients for a diet to remain isocaloric, 
nutrients which may have an independent effect on CHD risk.  
Considering geographical differences in SFA intake and CHD mortality the efficacy of 
basing UK dietary guidelines on evidence of other countries is questionable. Evidence 
from within the UK is not convincing. The three secondary prevention trials, all of men 
reported no significant benefit of fat modification (Rose, Thomson, & Williams, 1965) 
(MRC, 1968) or reduction (Ball, et al., 1965). No primary prevention control trials were 
identified to have been completed on UK populations. Similarly evidence from UK 
based cohort studies were not convincing with only Mann, Appleby, Key, & Thorogood 
(1997) reporting a clear positive association albeit in health conscious individuals. 
Boniface & Tefft, 2002 reported an association in women but not men which highlights 
the need for further investigation of SFA and females, furthermore it suggests that a 
one size fits all dietary guideline may not be adequate.  
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It is clear evidence to support the Uk dietary guidelines recommendation to replace  
energy from SFA with carbohydrates is lacking with only a single study  identified to 
have tested a reduced fat and increased carbohydrate diet (Ball, et al., 1965). The 
study by Reidlinger et al  (2015) is the first to specifically test UK dietary guidelines and 
a step forward in establisng their efificay however with no endpoints the long term 
effect has not been established. Furthermore relience on CHD risk factors such as 
serum lipid levels to calculate risk may be undermined by the evidence considered 
here which  questions  the association between cholesterol and CHD.  
This review did not consider multiple intervention trials apart from Reidlinger et al  
(2015) due to inability to isolate the effect of a single nutrient, however it may be that 
overall diet and  lifetyle has a greater effect than reduction of a single nutrient as 
nutrients are rarely eaten in isolation. 
The long term effect of UK dietary guidelines in unknown there is a clear need for 
further investigation between CHD mortality and dietary trends, if SFA is a major 
dietary risk factor for CHD then have intakes changed in conjunction with declining 
CHD mortality and what effect if any have UK dietary guidelines influenced diet.  
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equal doses. Olive 
Oil (n26), Corn Oil 
(n28). Control n26. 
Oil groups given 
advice to avoid 
fried foods, fatty 
meat, sausages, 
pastry, ice cream, 
cheese and cakes.  
2 Years Mean 58g 
olive oil 
consumed, 
64g Corn Oil. 
Feel to 51g a 







Corn Oil sig drop 
in cholesterol 
during first 18 
months (P<0.01) 
but not sig lower 
from baseline 
after 18-
24months. No sig 
dif In Control or 
Olive Oil groups.  
After two years 
75% of Control 
remained free of 
cardiac events 
compared to 57% 
of Olive Oil and 













 412 Men 30-














aimed at lowering 
serum cholesterol. 
Advice to consume 
diet low in animal 
fat and cholesterol 
while high in 
vegetable oils 











17.6% lower in 
intervention from 
baseline after 5 
YRS vs 3.7% lower 
in Control 
At 5 YRS sig ↓ 
major CHD 
relapses (p0.05) in 
intervention 
group, no sig dif in 
non-fatal MI. At 
11 years Sig ↓ MI 
mortality. Overall 
CHD & Total 
mortality not sig 

























 Intervention group 
prescribed low fat 
diet with 45g Fat. 
Control Usual Diet 
with 110-130g Fat. 
Overweight given 
calorie controlled 
diet (21% Control, 
15% Intervention)  
Mean 3 Yrs.  Weighted Food 
diary once a 
week on 
different days 
for first 7 
weeks then 
once a month 
44mg/dl drop in 
intervention from 
baseline. 25mg/dl 
drop in control.  
No sig difference 
between groups in 
relapses or 



















Subjects (n) Location Study Design Blinding Intervention Follow Up Diet Dietary Analysis Effect on 
Cholesterol 
Effect on CHD 
Mortality / Events 




















(n199) diet low in 
SFA with 85g Soya 
bean oil daily. 
Control (n194) 
usual diet 
2 - 6.75 YRS 
Mean 
3.5YRS 
 Weight food 
diary 
Experimental diet 
↓ SC during first 




group fell 6%. 
No significant 
difference in 
relapse of CHD 
deaths.  Relapses 































Australia RCT, parallel 
groups  
single Intervention: 
advice to limit SFA 
intake to less than 
10% TEI and 
increase PUFA to 
15% TEI using 
safflower oil & 
safflower 
margarine.  
Control no advice  
Median 
39months 
 7 day food logs 
completed 
three times in 
the first year 
and every six 
months 
12 month sig drop 







group was 17.6% 
vs 11.8% in 
control group 
P<0.05). 
CHD mortality sig 
(P<0.036) higher 
in intervention 
(16.3%) vs control 









et al 1967 











 Two Intervention 
groups; Diet 1 
(n50) 1oz corn & 
safflower oil mix. 




PRO, 51.8% CHO. 
Diet 2 (n50) 1oz 
Coconut Oil & 





1Yr due to 
lack of 
difference in 







 Interview No sig difference 
between Diets. 
Both Diets 
lowered TC in first 
year.  














Subjects (n) Location Study Design Blinding Intervention Follow Up Diet Dietary Analysis Effect on 
Cholesterol 
Effect on CHD 
Mortality / Events 
3.3%PUFA) 20.7% 
PRO, 51.1% CHO.  
Control (n100) 
Usual Diet.  
 
 
Summary Table 3: Cohort Study Summary Table 
Study / 
Review 
Study Name Population CHD 
Status at 
Baseline 









Results SFA linked 
with CHD? Energy 
(Kcal) 

















At 1 year 20YRS PUFA inversely associated 
with CHD death risk (p0.10). 
DC positively associated with 
CHD death risk. SFA linked 
with TC.  
No 
Paul et al 
1963 
“ ”            














24hr recall None 10YRS Total CHD (P< 
0.05) & MI or CHD Death 
(P<0.001) associated With 
relative but not absolute 
intake of either total or SFA 
fat. Multivariate analysis 
removed significance of %TE 
SFA with total CHD or angina 
however still associated 
along with total fat with MI 

























FFQ None 20YRS %TE SFA related to CHD 
mortality (p0.005). No sig 
difference in SFA or PUFA 






Study Name Population CHD 
  
 









Results SFA linked 
  origin living 
in Boston or 













without CHD and CHD 
deaths.  
Brothers living in Ireland 
lower CHD mortality than in 
Boston.  
Posner et al 
1991 





Without USA N813 2643 ( age 
adjusted)  








24hr Recall  none 16YRS Men Aged 45-56 Energy 
adjusted %TE SFA 
significantly associated with 
CHD (p0.050) but not 
unadjusted, multivariate or 
absolute intake. Men aged 
56 or more no relationship 
between SFA or TF & CHD. 





as %TE but 
not g/day.  
NO in 
others.  
Fehily et al 
1993 


















food diary.  
None 5YRS No significant relationship 
between CHD and either 

























FFQ None 14YRS Age adjusted significant 
relationship between SFA & 
MI (p0.002) and CHD 
mortality (p0.0001). 
Multivariate analysis 
removed significance.  
No 
Mozaffarian 
et al 2005 
“ “            
Mozaffarian 
et al 2006 
            
He 2003 “ ”14 Yrs. 
follow up 
           






Without USA N4546  SFA Intake CHD 
Death 40.8g 30-
24hr recall None 12YRS Significant relationship 







Study Name Population CHD 
  
 









Results SFA linked 





59YRs  29.9% 
60-79YRS 
CHD mortality in men and 
women aged 30-59 (P<0.01) 
but not in those aged 60-79. 




age groups.  
Mann et al 
1997 
Oxford 

















Women 38.1g  
FFQ None 13YRS Saturated animal fats intake 
associated with CHD 
mortality (P<0.01). 
















Without Finland N 
21930 
NA First quintile TF 
83.2g, SFA 





FFQ None 6YRS No association between SFA 

















Without UK N2676 NA NA FFQ None 16YRS SFA not related to risk of 
CHD death in men but was in 
older women aged 60-75Yrs 
(p0.0023). SFA was linked 
with death from other 
causes in women 40-59Yrs 























14.5% to 24.8%. 
Women TF 
36.6% to 54.4%. 








None 16YRS No association with either 
total or any type of fat with 
risk of CHD. 
In Women 5% increase in 
SFA resulted in 36% 
increased risk of CHD.   
Yes in 
Women  
No in Men 
Leosdottir 
et al 2007* 
Malmo Middle aged 
Men and 
women  
Without Sweden N28098 Men 2425 
to 2808 
women 






None 8YRS No significant association 
between SFA, total fat or 






Study Name Population CHD 
  
 









Results SFA linked 




to 21.3%.  




Men PUFA 5.5% 
to 7.1%, 





“    ”            






30-55 free of 
CVD and 
diabetes 







quintile 10.1% - 
highest 17.6%.  
TF 28.3% to 
44%. PUFA 
4.1% - 7.4%. 
FFQ  5 times 20YRS Age adjusted positive trend 
with SFA intake (p0.0001) or 
Total fat intake (p0.001) 
with CHD risk. Multivariate 
analysis removed 
significance.  
YES & NO 
Albert 2005 “ ”            
Iso 2001 “ ”            











           
Hu et al 
1999 
            












Death 13.8%.  
7 day food 
diary 
4 times 18YRS Low SFA intake not 
protective of CHD incidence 
(p0.005). Each gram of SFA 
related to 7% increased risk 
of CHD death (P<0.001) 
however results grouped 
with low Fruit and vegetable 
intake*.   
NO* 





Study Name Population CHD 
  
 









Results SFA linked 










CHD 1672.  
NON-CHD TF 
35.8%,SFA 
12.1% (26.1g)  











and CHD Overall. Higher 
intake of SFA, total fat and 
MUFA associated with 
higher CHD mortality in 





et al 2010 





from CHD  






















FFQ none 14 SFA not associated with CHD 
mortality. 
Age and sex adjusted 
relationship between SFA 
and risk of CVD (P<0.001) 
and MI (p0.03). Multivariate 
analysis removed 
significance of SFA and MI 
and lowered relationship 
between SFA and CVD 
(p0.05). 




























Women CHD TF 
92g/day, SFA 
53g/day. Alive 
TF 88g/day, SFA 
50g/day.  
Interview Twice 14 SFA not related to CHD 
mortality 
NO 


















Alive TF 28.5% 
(90.8g), SFA 9% 
(28.9g).  
CHD Death TF 
26% (76.9g), 




None 15 SFA protective against CHD 
mortality and total 
mortality. SFA intake 
significantly different 
between survivors and those 






Study Name Population CHD 
  
 









Results SFA linked 
  45-64Yrs All Cause Death 
TF 26.7% 
(83.5g) SFA 
8.5% (26.9g)  
Kromhout 
et al 1984 
Zutphen Men  aged 
40-59 
Without Netherlands N871 CHD 2531 
Non-CHD 
3055 









None 10 SFA intake significantly 
lower in men who 




Zutphen            
Oomen 
2001 
Zutphen            
Streppel 
2008 





























Urban TF 36.6% 
(99g), SFA 
13.5% (37g) 
Rural TF 32.2% 
(86g) SFA 12.6% 
( 33g) 
CHD Urban TF 
38% (98g), SFA 
13.6% (36g). 
Rural TF 32.3% 
(81g) SFA 13.1%  
(33g) 
24hr recall None 6 No difference in SFA intake 
between men with or 
without CHD.  
NO 









Without UK N337 Range 
1860-4440 
Range of TF 30-
56%  




None  No relationship between SFA 
or Total fat and CHD 
NO 
Kromhout 





Not Clear Various N12763 See Full 
Paper 
See Full Paper 
Table 1. SFA 
Weighed 
food diary 
Yes in 7 
of 16 
25 SFA (P<0.001) & total fat 






Study Name Population CHD 
  
 









Results SFA linked 















of the seven 
countries 
study. 




cohorts year mortality rate  
Kromhout 








           
 
 
Summary Table 4: Systematic reviews & Meta-analysis 
Author & Year Stated aim of review Funding Number Papers Cited Study Selection Conclusion 
Chowdhury et 
al (2014) 
To Surmise evidence about associations 




Cambridge Institute for 
Health Research 
Biomedical Research 
Centre and Gates 
Cambridge.  
76, 32 Observational Studies 
of Fatty Acids from dietary 
intake, 17 observational 
studies of fatty acid 
biomarkers. 27 RCT’s of fatty 
acid supplementation.   
Prospective, observational studies with >1 YR 
follow up. RCT which recorded coronary 
outcomes as endpoint.  
Current evidence does not 
clearly support cardiovascular 
guidelines that encourage high 
consumption of 
polyunsaturated fatty acids 
and low consumption of total 
saturated fats. 
Siri-Tarino et al 
(2010)  
To surmise the evidence related to the 
association of dietary saturated fat with 
risk of CHD, stroke and CVD  in 
prospective epidemiological studies 
National Dairy Council, 
National centre for 
research resources. 
21 cohort studies , (16 on 
CHD and 8 on Stroke) 
Prospective cohort studies which specifically 
evaluated SFA with CVD measured dietary 
SFA, fatal or non-fatal CVD events but not 
CVD risk factors, Healthy participants at 
baseline. 
Prospective epidemiological 
studies show no significant 
evidence for concluding that 
dietary saturated fat is 
associated with an increased 
risk of CHD or CVD.  
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Author & Year Stated aim of review Funding Number Papers Cited Study Selection Conclusion 
Jakobsen et al 
2009 
To investigate associations between 
energy intake from MUFAs, PUFAs and 
CHO with CHD risk while assessing 
potential effect of age and sex 
National Heart, Lung 





11 cohort studies Inclusion Criteria: published follow up study 
with >150 coronary events, avaibliity of usual 
diet, validated dietary assessment method. 
Excluded were subjects <35 Yrs., any previous 
history of CVD, diabetes or cancer and 
extreme energy intake.  
Associations suggest that 
replacing SFAs with PUFAs 
rather than MUFAs or CHO 
prevents CHD over a wide 






Examine effects of PUFA interventions on 
risk of CHD 
Life insurance medical 
research fund of 
Australia and New 
Zealand. National 
institutes of health. 
8 RCT on PUFA intervention 
on secondary prevention. 
Randomised trials which increased PUFA in 
place of SFA reporting 
non-fatal MI, CHD deaths and/or 
Total deaths. Excluded if CHD risk 
disproportionate in study arms; or dietary 
information necessary to classify 
experimental diets 
As either ‘n-6 specific PUFA’ or ‘mixed n-3/n-6 
PUFA’ was not available. 
 
Finds no benefit of 
cardiovascular benefit in 
linoleic acid interventions trials 
Skeaff & Miller 
2009 
To assist the expert consultation group to 
make evidence-based recommendations 
about fat, fatty acids and human health. 
Not clear 28 Cohort, 9 Control trials  Low fat or PUFA-SFA interventions with CHD 
endpoints 
“Available evidence from 
cohort and RCT trials is 
unsatisfactory and unreliable 
to make judgment about and 
substantiate the effects of 
dietary fat on risk of CHD” 
Mente et al 
2009 
To systematically evaluate dietary 
exposures and CHD using Bradford Hill 
criteria, determine which RCTs on dietary 
exposure support findings of prospective 
cohort studies and which exposures have 
insufficient evidence.  
No external funding EXLUDED AS Multifactorial   
Cochraine 
Hooper et al 
2012 
To assess the effect of reduction and/or 
modification of dietary fats on mortality, 
cardiovascular mortality, cardiovascular 
morbidity and individual outcomes 
including myocardial infarction, stroke 
and cancer diagnoses in randomised 
clinical trials of at least 6 months 
duration. 
Cochraine  Inclusion criteria, randomised and 
appropriate control group; Stated aim of 
intervention was reduction or modification of 
intake of dietary fat or cholesterol unless 
intervention was specifically omega 3, trials 
non multifactorial, adults with or without 
CVD, intervention at least 6months, included 
mortality or CVD morbidity.   
“findings are suggestive of a 
small but potentially important 
reduction in cardiovascular risk 
on modification of dietary fat, 
but not reduction of total fat, 
in longer trials” 
Mozaffarian et 
al 2010 
To asses impact of increase PUFA 
consumption as replacement for SFA on 
CHD endpoints 
National Heart, Lung 
and Blood Institute & 
Chicago Community 
Trust Searle Scholar 
award 
8 RCTs which increased PUFAs for at least 1 
year without any other intervention, had an 
appropriate control group, reported sufficient 
data to calculate risk estimates with standard 
errors for effects on hard CHD events. 
Observational, non-randomised and omega 3 
Findings provide evidence that 
consuming PUFA in place of 




Author & Year Stated aim of review Funding Number Papers Cited Study Selection Conclusion 
dominant studies excluded. Not limited to 
primary or secondary trials.  
 
 
Summary Table 5: Observational Studies listed in Reviews. FU Follow up YR Years  
Study / Review Study Name Siri-Tarino 
et al 2001 
Jokobsen et 
al 2009 
Chowdhury et al 2014 
SFA Cohort Studies (20)  
Skeaff & Miller 
2009 
Skeaff & Miller 2009 WITH 
Listed SFA Intake SUPP Table 7 
Shekelle et al 1981 Western Electric X  X X 19Yr FU x 
Paul et al 1963 “ ”    X 4Yr FU X 
McGee et al 1984 Honolulu Heart X  X X (also Gordon et 
al 1981) 
X (also Gordon et al 1981) 
Kushi et al 1985 Ireland-Boston Diet-Heart X  X x x 
Posner et al 1991 Framingham X  X x x 
Fehily et al 1993 Caerphilly X  X x x 
Goldbourt et al 
1993 
Israeli IHD X x X x x 
Asherio et al 1996 Health Professionals Follow Up  X x X x x 
Mozaffarian et al 
2005 
“ “   X   
Mozaffarian et al 
2006 
    X  
He 2003 “ ”14 Yrs follow up   X   
Esrey et al 1996 Lipid Research Clinics  X  X x x 
Mann et al 1997 Oxford Vegetarian   X  X x x 
Pietinen et al 1997 Alpha-Tocopherol … X x X  x 
Boniface and Tefft 
2002 
Health & Lifestyle Survey X  X x x 
Jakobsen et al 2004 Glostrup Multi Centre X x X   
Leosdottir et al 
2007* 
Malmo X  X    
Wallstrom 2012 “    ”   x   
Oh et al 2005 Nurses Heart Study X  X X x 
Albert 2005 “ ”   X X  
Iso 2001 “ ”   X   
Hu et al 1997 Nurses Health Study DIETARY FAT INTAKE AND THE RISK OF 
CORONARY HEART DISEASE  
IN WOMEN 
 X  X x 
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Study / Review Study Name Siri-Tarino 
et al 2001 
Jokobsen et 
al 2009 
Chowdhury et al 2014 
SFA Cohort Studies (20)  
Skeaff & Miller 
2009 
Skeaff & Miller 2009 WITH 
Listed SFA Intake SUPP Table 7 
Hu et al 1999     x  
Tucker et al  Baltimore Longitudinal  X  X x x 
Xu et al 2006 Strong Heart  x  X x x 
Erkkila 2003 Euroaspire   x x  
Trichopoulou 2006 EPIC Greece   x   
Yamagishi et al 
2010 
JACC -  Japan Collabortive   x   
Folsom et al 1997 ARIC Atherosclerosis Risk in communities  X    
Yamagishi et al 
2008 
“”    x x 
Wang, Folsom, 
Eckfeldt 2003 
“”     x 
Laaksonen 2005 Kuopio IHD   x   
Fraser et al 1992 Adventist Health Study  X    
Knekt et al 1994 Antioxidant Vitamin Intake and Coronary Mortality in a 
Longitudinal Population Study 
 X    
Kushi et al 1996 DIETARY ANTIOXIDANT VITAMINS AND DEATH FROM CORONARY 
HEART DISEASE IN  
POSTMENOPAUSAL WOMEN 
 X    
Hallmans et al 
2003 
Northern 
Sweden Health and Disease Study Cohort 
 X Not included in SFA  but 
circulating FA 
  
Liu et al 2002 Womans Health Study (WHS)  x    
Farchi et al 1989 7 countries Italy Rural 20yr mortality    x x 
Khaw et al 1987 California      
Kromhout et al 
1984 
Zutphen    x X 
Oomen et al 2001 Zutphen   Not included in SFA but 
Omega 3  
X  
Oomen 2001 Zutphen   “    ” X  
Streppel 2008 Zutphen   “     ”   











Rico Heart Health (PRHH) 
   x x 
Miettinen et al 
1982 
Nested case control    X x 
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Study / Review Study Name Siri-Tarino 
et al 2001 
Jokobsen et 
al 2009 
Chowdhury et al 2014 
SFA Cohort Studies (20)  
Skeaff & Miller 
2009 
Skeaff & Miller 2009 WITH 
Listed SFA Intake SUPP Table 7 
Morris et al 1977 Diet and heart: a postscript  London 1956    x x 
Tanasescu et al 
2004 
Dietary fat and cholesterol and the risk of 
cardiovascular disease among women with type 2 
diabetes 
 
     
Kromhout et al 
1995 
Dietary Saturated and transFatty Acids and Cholesterol and 25-
Year Mortality from Coronary Heart Disease: The Seven Countries 
Study 
 
   x x 
Kromhout et al 
1989 
Food consumption patterns in the 1960s in seven countries 
 
     
Salonen et al 1985 Nested case control     x 
Ohrvall et al 1996      x 
Albert et al 2002      x 












Summary Table 6: Control Trials Included in Reviews MF  Modified fat, RF  Reduced Fat, R&MF  Reduced and Modified fat 





Sex Mozaffarian et 
al 2010 
Chowdhury (27 
total 8 PUFA for 
SFA 
Skeaff & Miller 2009 (taken 
from Supp Table 18 RCT 
FAT MODIFIED DIETS 




Hooper 2012 Cochraine  
Analysis 1.3 Combined CVD 
Events  
Analysis 1.2 CVD 
Mortality 
Dayton 1969 LA Veterans With & 
Without 
M x X  X  (P/S Events) X X (MF)  
MRC 1968 
(Morris et al) 
MRC Soya Oil With M X X X (P/S Deaths)  
(P/S Events) 
X X (MF) X (MF) 
Leren 1970 Oslo Diet-Heart With M X X X (P/S Deaths) 
(P/S Events) 
X   
Leren 1996 “ ”       X (MF) X (MF) 
Turpeinen 1979 Finnish Mental 
Hospital (Men) 
Without M X X Combined 
results  
X (P/S Deaths) (P/S Events)    
Miettinen 1983 Finnish Mental 
Hospital 
(Women) 
Without W X X(P/S Deaths) (P/S Events)    
Frantz 1989 Minnesota 
Coronary Survey 
Without M&W X X X (P/S Events) X (Splits  study 
into M&W) 
X (Splits  study into M &W) X (Splits  study 
into M &W) 
Burr 1989 DART With (Multi)  X X X (P/S Deaths) (P/S Events) X (excluded from 
main analysis)  
X (R&MF) X (R&MF) 
Watts 1992 S.T.A.R.S With (Multi)  X X* 1994 paper X (P/S Deaths) (P/S Events) X X (R&MF) X (R&MF) 
Rose et al 1965 London Corn Oil  With  M   X (P/S Events) X X (MF) X (MF) 




With M  X  X   
Ball et al 1965 London Low Fat 
Low-fat diet in 
myocardial 
infarction 
With M   X (LOW FAT)  X (RF) X (RF) 
De Lorgeril et al 
1999 
Lyon Diet Heart 
Study 
    X (not listed in main paper)    







W   X (LOW FAT)  X (RF) Split into With & 
Without CVD 
X (RF) Split into 
With & Without 
CVD 
Tuttle et al 2008 THIS-DIET     X (not listed in main paper)    
Houtsmuller 
1979 





       X (R&MF) All on Statins X (R&MF) 
MeDiet 2002        X (R&MF) Breast Cancer  
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Sex Mozaffarian et 
al 2010 
Chowdhury (27 
total 8 PUFA for 
 
Skeaff & Miller 2009 (taken 
from Supp Table 18 RCT 
   




Hooper 2012 Cochraine  
Premier 2003        X (RF) Multiple Intervention 
High Blood Pressure 
 
NDHS 1968 National Diet 
Heart Study 
      X(MF & R&MF) 
Feasibility trial  
 
Black 1994        X (RF) 
Skin Cancer 
X (RF) 
Ley 2004        X (RF) Diabetics X (RF) 
Moy 2001        X (RF) Hypercholesterolemia   
DO-IT 2006        X (RF) Omega 3 
Supplementation  
X (RF) 








Trends in Saturated Fat, Total Fat and Coronary Heart 
Disease in the United Kingdom 1950-2010: Does the 
evidence support current dietary guidelines. 
 




Journal Choice: The journal chosen if this paper were to be published is Open Heart, an 
open access online journal co-owned by the British Medical Journal and British 
Cardiovascular Society. The journal has published a number of papers on the 
relationship between saturated fat and coronary heart disease and has a stated aim to 
be open and have maximum impact on research progress and patient care while 















Background and aims 
The aim of this study was to evaluate the relationship between saturated fat, total fat 
and coronary heart disease (CHD) at United Kingdom (UK), national and regional level 
and to establish if available data supports current dietary guidelines for the reduction 
of total and saturated fat intake. 
Methods 
Data was sought pertaining to historical trends in dietary intake, CHD mortality and 
associated measures within the UK. Trends were then analysed to establish if a 
relationship, if any existed between measures.  
Results 
Results show that from a peak in 1978 male CHD mortality to 2010 fell by 79% in men 
and 83% in women. In the same period relative saturated fat intake fell by 4.6% and 
total fat by 3.4%. Analyses showed at the UK population level there was a consistent 
significant positive association between saturated fat intake and coronary heart 
disease mortality in men and women between 1972 to 2010 (P<0.01). The relationship 
between total fat intake and CHD was less consistent as were associations at national 
and regional level. There was no association between saturated fat intake, total fat 





The results of this study support current population dietary guidelines however the 
disparity between the percentage change between saturated and total fat intake 
compared to the decline in CHD mortality over time questions the impact saturated fat 





















Coronary heart disease (CHD) is the leading single cause of death in the United 
Kingdom (UK) accounting for 73,680 deaths in 2012 (Townsend, Williams, Bhatnagar, 
Wickramasinghe, & Rayner, 2014). Interest in the relationship between total fat intake 
(TF), saturated fat consumption (SFA) and CHD after World War Two in the UK led to 
the development of a Committee on Medical Aspects of Food Policy (COMA) panel on 
diet and CHD and publication of dietary guidelines (DHSS, 1974) (Bufton, 2005).  
Current dietary guidelines for the prevention of cardiovascular disease (CVD) were 
published in 1994 and recommend the reduction of the percentage total energy intake  
(%TE)  of  TF to 35%TE and SFA to 10%TE due to evidence suggesting lower intakes may 
lower risk of CHD, lower cholesterol levels and prevent obesity (DOH, 1994).  
In recent years the relationship between SFA and CHD has been questioned 
(Chowdhury, et al., 2014), (Siri-Tarino, Sun, Hu, & Krauss, 2010), (Harcombe, et al., 
2015). The purpose of this study is to evaluate this relationship in the UK at a national 
and regional level and to establish if available data supports current dietary guidelines.  
Method 
Data collection 
Historical diet and age specific mortality and population data pertaining to the UK was 
identified using searches of the Office for National Statistics (ONS), World Health 
Organisation (WHO), Department of Health (DOH) and Department for Environment, 
Food and Rural Affairs (DEFRA).   
58 
 
UK, England & Wales, Northern Ireland (NI) and Scottish mortality and population data 
were collected from the WHO cause of death database (World Health Orginization, 
2015). UK mortality data was available for the years 1950 to 2010 apart from 1998 to 
2000. International Statistical Classification of Diseases and Related Health Problems 
(ICD) codes for CHD used were as follows: ICD-7 A081, ICD-8 A083, ICD-9 410-414 and 
ICD-10 I20-I25 (Moran, et al., 2012). The age range was selected to cover those most at 
risk of preventable CHD with 40 the age from which the National Institute for Health 
and Care Excellence (NICE) recommend CVD risk is reviewed (NICE, 2014) and deaths 
below the age of 75 considered premature (Townsend, Williams, Bhatnagar, 
Wickramasinghe, & Rayner, 2014).Regional mortality and population data was 
provided by the ONS (ONS, 2014) (ONS, 2013). 
Dietary intakes were sought to match against available mortality data. Household UK 
dietary intakes were available from the National Food Survey (NFS) between 1950 and 
2000 (DEFRA, 2013). Combined household and eating out intakes were available for 
2001-2010 from the Family Expenditure Survey (EFS) and Living Costs and Food Survey 
(LCFS) (DEFRA, 2014) and at national and regional level (DEFRA, 2015). As England & 
Wales mortality was combined the mean dietary data from the two countries was 
used.   
CHD prevalence was available for England from the Health Survey for England (HSE) 
(HSE, 2012) and Scotland Health Survey (SHS) (SHS, 2013). Age specific UK total 
cholesterol (TC) trends were not identified so age standardised estimates for men and 
women aged over 25 were taken from the Global Health Observatory Data Repository 
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(WHO, 2014). Where datasets contained data that predated available country level 
dietary intakes UK dietary data was used for consistency.   
Statistical analysis 
Corresponding age specific mortality and population data for male and females aged 
40-74 was extracted from collected data using Microsoft Excel 2010 and calculated 
into a per 100,000 mortality rate. This was done by dividing gender age specific CHD 
mortality by corresponding age and gender population and multiplying by 100,000.  
Data which failed to achieve normality of distribution was analysed using Spearman’s 
rank correlation (rs). Normally distributed data was analysed using Persons moment 
correlation (r). Correlations were performed using SPSS (Version 22.0). Correlations 
were compared against the Cohen & Holliday (1996) classification to assess the 
strength of relationship (Cohen & Holliday, 1996).  
Results 
UK Trends 
Historical trends for SFA%TE, TF%TE and CHD are shown in figure 1, in the UK CHD 
mortality in those ages 40-74 peaked in 1978 in males at 710 deaths per 100,000, 
female mortality also spiked in 1978 at 275 deaths per 100,000 second only to a peak 
of 288 deaths per 100,000 deaths recorded in 1951. From 1978 Male CHD mortality 
declined by 79% to 149 deaths per 100,000 in 2010. Female CHD mortality dropped by 
83% from 1978 and 84% from 1951 to 47 deaths per 100,000 in 2010.  From 1978 to 




Figure 1: Trends in dietary SFA%, TF%TE and CHD mortality in the UK 1950 to 2010 
 
Mean intakes and mortality rates for the UK and constituent countries are listed in 
Table 1 and correlations displayed in Table 2. From 1950 to 1997 there was a 
significant modest correlation in men (rs =0.49,P<0.01) and low correlation in women 
(rs =0.34,P<0.01) between CHD and absolute total fat intake (g) . From 1972 to 1997, 
the time period where SFA intake from the NFS is available, the relationship changed 
to very high in both men (rs=0.94,  P<0.01) and women (rs= 0.93, P<0.01). The 
significance and strength of correlation remained during the EFS and LCFS survey 2001 
to 2010. The relationship between relative TF%TE intake was less strong apart from a 
significant high correlation (P<0.01) when spanning NFS, EFS and LCFS surveys  in men 














































































Female CHD Mortality 40-74 per 100,000 Male CHD Mortality 40-74 per 100,000
NFS Total Fat Intake %TE 1950-2000 NFS SFA %TE 1950-2000
EFS & LCFS Total Fat Intake %TE 2001-10 EFS & LCFS SFA %TE 2001-10
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intakes of SFA were significantly highly to very highly correlated with CHD mortality 
(P<0.01). 
Table 1: Mean diet and CHD mortality  
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England & Wales*       
EFS & LCFS 2001-2010 194.3 
±41.2 
67.4 







Scotland       
EFS & LCFS 2001-2010 252.8 
±45.4 
100.2 







Northern Ireland       
EFS & LCFS 2001-2010 207.1 
±39.1 
77.5 
















Table 2: Correlation between  dietary SFA, TF and CHD Mortality  
  Time Period Male CHD Mortality Ages 40-74 per 100,000 
Female CHD Mortality Ages 
40-74 per 100,000 
Total Fat  UK   
g  NFS 1950-1997 rs=0.49** rs =0.34* 
  NFS  1972-1997 rs =0.94** rs =0.93** 
  EFS & LCFS 2001-2010 r=0.89** r=0.89** 
  England & Wales  
  
  EFS & LCFS 2001-2010 r=0.84** r=0.85** 
  Scotland    
  EFS & LCFS 2001-2010 r=0.16 r=0.10 
  Northern Ireland    
  EFS & LCFS 2001-2010 r=0.27 r=0.35 
Total Fat  UK   
%TE  NFS 1950-1997 rs =0.64** rs =0.12 
  NFS, EFS & LCFS 1950-2010 rs =0.71** rs =0.34** 
  NFS  1972-1997 rs =0.50** rs =0.49* 
  NFS SFA, EFS & LCFS 1972-2010 rs =0.78** rs =0.77** 
  EFS & LCFS 2001-2010 r=-0.59 r=-0.58 
  England & Wales    
  EFS & LCFS 2001-2010 r=-0.30 r=-0.29 
  Scotland    
  EFS & LCFS 2001-2010 r=-0.18 r=-0.29 
  Northern Ireland  
  
  EFS & LCFS 2001-2010 r=-0.15 r=-0.89 
SFA  UK   
g  NFS 1972-1997 rs =0.95** rs=0.94** 
  EFS & LCFS 2001-2010 r=0.94** r=0.94** 
  England & Wales    
  EFS & LCFS 2001-2010 r=0.89** r=0.89** 
  Scotland    
  EFS & LCFS 2001-2010 r=0.75* r=0.71* 
  Northern Ireland    
  EFS & LCFS 2001-2010 r=0.53 r=0.59 
SFA  UK   
%TE  NFS 1972-1997 rs =0.96** rs=0.96** 
  NFS, EFS & LCFS 1972-2010 rs=0.98** rs=0.98** 
   EFS & LCFS 2001-2010 r=0.80** r=0.81** 
   England & Wales    
  EFS & LCFS 2001-2010 rs =0.67* rs =0.67* 
  Scotland    
  EFS & LCFS 2001-2010 rs =0.62 rs =0.62 
  Northern Ireland    
  EFS & LCFS 2001-2010 r=0.62 r=0.64* 
 **Significant to P<0.01 *Significant to P<0.05 
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National Trends  
Between 2001 and 2010 CHD mortality fell in all countries within the UK. In England 
and Wales male CHD mortality fell 45% from 262 to 144 deaths per 100,000, female 
CHD mortality fell 54% from 98 to 45 deaths per 100,000. In the same period relative 
SFA intake fell by 0.54%TE to 13.8%TE with absolute intake declining by 11% from 
39.3g to 35.0g. TF rose by 0.2%TE to 37.4%TE but absolute intake fell 7% from 102.4g 
to 95.2g. In Scotland Male CHD mortality fell by 40% from 320 deaths per 100,000 to 
193, female CHD mortality fell by 49%, from 137 to 70 deaths per 100,000. During this 
time SFA intake fell by 0.7%TE to 13.7%TE and absolute SFA by 5% from 38.9g to 36.8g. 
In Northern Ireland CHD male mortality fell by 40% from 271 to 162 deaths per 
100,000, female CHD mortality fell 53% from 114 to 53 deaths per 100,000. SFA intake 
fell 0.8%TE to 13.5%TE and absolute intake by 13% from 39.7g to 34.5g. TF intake fell 
by 0.2%TE to 36.2%TE with absolute intake declining by 9% from 101.5g to 92.4g.  
Absolute TF (g) but not %TE was significantly highly correlated with CHD in males and 
females in England and Wales (P<0.01). TF was not significantly correlated with CHD in 
Scotland of NI. 
Table 2 shows absolute and relative SFA intake were significantly highly correlated 
with male and female CHD mortality in England & Wales (P<0.01) and with absolute 
intakes in Scotland (P<0.05). There was a significant (P<0.5) modest correlation 
between CHD and SFA %TE in females but not males in NI. 
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Differences within the UK 
Table 3 shows CHD mortality and dietary TF and SFA intake at UK, national and 
regional level in 2010. Scotland had the highest CHD mortality but has a lower relative 
TF and SFA intake than the UK as a whole. The South East of England had the lowest 
mortality rate however had a higher relative intake of TF and SFA than Scotland. 
Conversely absolute intake of TF and SFA are higher in Scotland than both the South 
East and UK overall.  
Table 3: CHD Mortality, TF and SFA intake in the UK, constituent countries and regions of England   in 
2010  
  

















UK 149 47 38.6 95.2 14.2 35.1 
Scotland 193 70 36.3 97.5 13.7 36.8 
England & Wales* 144 45 37.4 95.2 13.8 35.0 
NI 162 53 36.2 92.4 13.5 34.5 
North East 165 48 36.6 91.0 13.8 34.3 
North West 176 62 38.0 95.1 13.8 34.6 
Yorkshire and The 
Humber 163 57 37.4 94.8 13.8 35.0 
East Midlands 148 46 37.0 94.8 13.9 35.7 
West Midlands 154 47 37.1 92.0 13.4 33.1 
East of England 127 40 37.3 101.0 13.9 37.7 
London 120 37 38.0 91.3 13.4 32.1 
South East 115 32 37.7 94.9 14.2 35.7 
South West 124 35 37.6 100.6 14.0 37.5 
Mean 149.2 47.7 37.34 95.05 13.81 35.17 
SD ±23.2 ±10.9 ±0.69 ±3.16 ±0.28 ±1.59 
*Mean Combined England & Wales Diet 
 
At UK, national and regional level show there was no significant correlation between 
SFA, TF and CHD mortality in 2010. In females there was a high negative correlation 
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between female CHD and absolute TF intake when combining UK, national and 
regional data. At a national level there was a high correlation between absolute but 
not relative SFA intake, absolute TF intake was negatively correlated with CHD in both 
males and women. At regional level there was a low correlation between SFA, TF and 
CHD. 
Impact of Guidelines 
Table 4 shows recommended intakes from 1974 (DHSS, 1974), 1984 (DHSS, 1984) and 
1994 (DOH, 1994) guidelines for SFA%TE and TF%TE were not met.  Prior to the 
publication of the first COMA guidelines on diet and CHD there was a significant very 
high correlation as shown in Table 5 between TF% intake and male but not female CHD 
mortality (r=0.91, P<0.01). Between the 1974 guidelines and 1984 guidelines there was 
significant modest relationship between SFA %TE and female CHD mortality (r=0.66, 
P<0.05). Between the 1984 and 1994 guidelines both male and female CHD mortality 
was very highly correlated with SFA%TE and TF%TE intake (P<0.01). From the 
publication of the 1994 guidelines to 2010 a significant very high correlation remained 





























581.9 ±65.2 256.8 ±11.0 39.33 ±2.33 - - - 
Between 1974 & 
1984 guidelines 680.1 ±23.8 265.7 ±6.1 42.16 ±0.41 Reduce 19.05 ±0.64 Reduce 
Between 1984 & 
1994 guidelines 531.0 ±75.2 219.9 ±8.5 41.83 ±0.62 35% 17.00 ±0.85 15% 
Current Guidelines 
1994-2010* 252.4 ±94.2 95.4 ±44.1 38.76 ±0.74 35% 14.85 ±0.43 10% 
*2001-2010 dietary data includes eating out 
Table 5: Correlation between UK CHD Mortality Ages 40-74 per 100,000, TF and SFA 
 Gender TF %TE   SFA%TE 
Pre 1974 Guidelines 1950-1974 Male r =0.91** - 
 Female rs =-0.14 - 
Between 1974 & 1984 guidelines Male r=-0.51 r=0.66* 
 Female r=-0.55 r=0.60 
Between 1984 & 1994 guidelines Male r=0.93** r=0.99** 
 Female r=0.94** r=0.99** 
Current Guidelines 1994-2010 Male rs=0.40 r=0.97** 
 Female rs=0.40 r=0.97** 
**Significant to P<0.01 
*Significant to P<0.05 
   
 
Prevalence 
Table 6 shows prevalence of CHD from the HSE and SHS. In England CHD prevalence 
has risen while both UK TF%TE and SFA%TE have fallen. In Scotland prevalence has 
fluctuated in men and fallen in women while Scottish dietary SFA%TE has fallen. TF%TE 
like male prevalence has fluctuated. Prevalence of CHD was higher in Scotland than 
England in 2003 with a lower intake of SFA and TF consumed in Scotland. Similarly 
mean prevalence although spanning different years was higher in Scotland with a 
lower mean intake of TF%TE and SFA%TE. 
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Table 6: CHD Prevalence , SFA and TF in England and Scotland in adults aged 16+ 
England  1994 1998 2003 2006 2008 2009 2010 Mean 
Male % 6.0 7.1 6.4 6.5 - - - 6.50 ±0.45 
Female % 4.1 4.6 4.1 4.0 - - - 4.20 ±0.27 
UK TF %TE 40.5 38.8 38.3 38.5 - - - 39.03 ±1.00 
UK SFA %TE 15.6 15.2 14.8 14.7 - - - 15.08 ±0.41 
 
Scotland 1994 1998 2003 2006 2008 2009 2010 Mean 
Male % - - 8.2 - 6.9 7.4 7.5 7.50 ±0.54 
Female %  - - 6.5 - 5.6 5.2 5.2 5.63 ±0.61 
TF%TE - - 36.8 - 37.0 37.1 36.3 36.80 ±0.36 
SFA%TE - - 14.5 - 14.3 14.1 13.7 14.15 ±0.34 
 
Neither relative SFA nor TF were significantly correlated with CHD prevalence. There 
was a high non-significant correlation between Scottish CHD prevalence and SFA%TE 
intake in women (r=0.82) but not men. In England there was a negative modest 
correlation between TF and CHD prevalence (r=-0.58).  
Saturated Fat and Cholesterol  
There was a  very high significant correlation between SFA %TE intake from the NFS, 
EFS and LCFS surveys (mean 16.15%TE ±1.50) with both male (mean 5.75mmol/l ±0.27, 
r=0.99, P<0.01) and female (mean 5.72mmol/l ±0.28, r=0.98, P<0.01) cholesterol levels 
between 1980 to 2009.  
Discussion 
The results of this study show a significant correlation between trends in SFA intake 
and CHD mortality in males and females aged 40-74 at a UK population level. The 
association is less consistent across nations although a relationship still exists. At a 
regional level there was a weak relationship between SFA or TF intake and CHD. The 
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association between TF and CHD however is less clear with the strength of the 
relationship dependent on time frame and gender. These findings are supported by 
Keys who reported a high correlation between CHD and SFA (r=0.84) but only a modest 
correlation with between TF (r=0.50) in the Seven countries study (Keys A. , 1980).  
The lack of association between regions may be due to the lack of available age 
specific mortality data with the single year comparison used not necessarily 
representative of longer term trends. Furthermore the smaller sample size and 
variation in population size may have confounded results.  The 1974 COMA panel 
noted the unexplained existence of regional differences in CHD mortality within the UK 
should prove cautionary in any application to the nation as a whole of advice based on 
the results of any dietary trial (DHSS, 1974).  
The relationship between TF and CHD between 1950 and 1997 is far weaker than 
between 1972 and 1997, the period that SFA intake is recorded consistently. This can 
be explained by the fact CHD mortality was still rising from 1950 and not peaking until 
1978. Differences in mean intakes over the period may also have affected the 
relationship with a higher absolute intake yet lower %TE intake between 1950 and 
1997 than 1972 and 1997, thus suggesting a difference in energy intake which was not 
examined in this study. This may also explain why between 1972 and 1997 absolute TF 
intake shows only a modest correlation with CHD yet a very high correlation with TF 
%TE. The disparity between absolute and relative intakes on significance has been 
reported in other studies (Posner, et al., 1991) (McGee, Reed, Yano, Kagan, & Tillotson, 
1984). Differences over time could be the result of a lag time between reduction of fat 
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and CHD with studies suggesting a lag time of five, ten or even twenty five years  (Law, 
Wald, & Thompson, 1994), (Kuulasmaa, et al., 2000), (Rose, 1982), (Law & Wald, 1999). 
While the findings of the study show a positive correlation between SFA and CHD and 
to a lesser extent TF and CHD it does not demonstrate a causal link, it does show 
however that over time SFA and TF intakes have fallen along with CHD mortality rates. 
The disparity between the 79% decline in CHD mortality in males and 83% in females 
from 1978 to 2010 compared to a 4.6% reduction in dietary SFA and 3.4% in TF intake 
over the same time period may undermine the veracity of association between SFA 
and CHD. This is supported by the non-association reported between CHD and SFA in 
UK observational studies (Fehily, Yarnell, Sweetnam, & Elwood, 1993), (Morris, Marr, & 
Clayton, 1977). However positive associations have been reported in the UK in health 
conscious men and women (Mann, Appleby, Key, & Thorogood, 1997) and in women 
aged 40 to 75 (Boniface & Tefft, 2002). A limitation of this study is that dietary data is 
not gender or age specific nor does it give information on socio economic status which 
may have affected results, although no clear pattern in TF or SFA and income was 
reported in the National Diet and Nutrition Survey (NDNS) (Public Health England, 
2014). 
The major weakness of this study is the dietary data used. The NFS was completed by a 
single diary keeper and made no account for food or drink purchased outside the 
home or without the diary keepers knowledge whereas in the EFS and LCFS diaries 
were kept by all household members (DEFRA, 2013). While adjusted historical intakes 
were available from 1974 to account for potential underreporting in the NFS the data 
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was not used as the adjustment made the assumption the level of underreporting was 
constant despite the intake of commonly underreported foods less common in 1974 
(DEFRA, 2013). The reduction in SFA and TF intake shown in this study is validated by 
data from the NDNS which also has recorded a decline (Department of Health, 2011). 
No account for food wastage or underreporting was made in this study which may 
have confounded results, analysis of NDNS data estimated 25% of male and females 
underreported (Rennie, Coward, & Jebb, 2007).  
A number of factors have influenced the decline in CHD mortality rates, It has been 
suggested that 58% of the decline in CHD is due to reductions in major risk factors with 
smoking alone accounting for 48% with the remaining 42% of the decline due to 
improved treatments (Unal, Critchley, & Capewell, 2005).  Similar findings for the 
effect of improved treatment on CHD have been reported in Scotland and England 
(Bajekal, et al., 2012) (Hotchkiss, et al., 2014). This is supported by the increase in 
prescriptions and surgical interventions in past decades, in England alone prescriptions 
to treat diseases of the circulatory system rose from 46,252 in 1981 to 285,530 in 
2010, in the UK the number of coronary artery bypass (CABG) surgeries and 
Percutaneous coronary interventions totalled 105,662 compared to 2,297 coronary 
artery bypasses in 1977 (Townsend, Williams, Bhatnagar, Wickramasinghe, & Rayner, 
2014) 
Comparison of countries within the UK demonstrates variations in CHD mortality, it has 
been suggested much of the mortality gap between England and Scotland is due to 
non-dietary factors with SFA intake across the countries having very little impact on 
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variation in mortality rates (Scarborough, Morgan, Webster, & Rayner, 2011). 
Geographical differences have been shown in other studies (Kushi, et al., 1985) 
(Marmot & Syme, 1976) which may explain differences between countries of the UK.  
The evidence supporting the introduction of UK dietary guidelines has been 
questioned (Harcombe, et al., 2015), to address this sub analysis of trends was carried 
out to assess the impact of each edition of dietary guidelines and the evidence before 
and since. Results were mixed but trends since the publication of current (DOH, 1994) 
and previous guidelines (DHSS, 1984) support the association between SFA%TE and TE 
with the significance remaining despite a drop in mean SFA intake over time. The 
association between SFA and CHD was however weaker prior to guidelines becoming 
policy in 1984 which may support the findings of Harcombe et al.  
 A recent randomised control trial demonstrated following current guidelines reduces 
risk of heart disease  (Reidlinger, et al., 2015) however it is clear recommendations 
have not been met yet CHD has continued to decline, would it be expected that a 
further reduction in SFA and TF result in a further decline?. The only trial identified to 
have tested a reduced fat diet reporting a null association with the low fat diet 
described as unpleasant (Ball, et al., 1965). The lack of adherence to recommendations 
may question if they are achievable or desirable, especially for those a low risk of CHD. 
If guidelines continue not to be met then perhaps a switch from population advice to a 
more targeted approach aimed at those at high risk may be more appropriate.  
Considering the relationship between SFA and TF with CHD mortality it would be 
expected that a similar reduction in CHD morbidity may be seen. The findings of this 
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study however dispute this although long term data at a UK level was not found which 
may have influenced results. This relationship can in part by explained by a higher 
survival rate resulting in an increase in prevalence (Davies, Smeeth, & Grundy, 2007) 
increasing the burden of the disease (Allender, Scarborough, O'Flaherty, & Capewell, 
2008). It has been suggested that better diagnostic techniques may have increased 
diagnosis rates and thus prevalence (Lampe, Morris, Whincup, Walker, Ebrahim, & 
Shaper, 2001). Furthermore improvements in diagnosis may explain the rise seen in 
CHD mortality up to the 1970’s (Lozano, Murray, Lopez, & Satoh, 2001). 
Long term data on TC levels was limited; the findings of this study demonstrate a 
significant positive correlation between TC and SFA%TE which supports the guideline 
advice to reduce SFA however the data used was not age specific which may have 
affected results. For this reason the relationship between CHD mortality and TC was 
not included in this study. There is evidence however that questions the association 
between TC and CHD (Prospective Studies Collaboration, 2007) (Bathum et al., 2013) 
(Schatz et al., 2001). 
A further limitation of the study is its clinical application, food choices were not 
analysed as the most recent COMA dietary guidelines (1994) do not recommend 
consumption or reduction of specific foods to meet targets. The lack of information 
pertaining to ethnicity and socioeconomic status information is not just a limitation of 
this study with the quality and availability of data relating to CHD in the UK criticised 
for being inadequate considering it is the largest cause of death (Unal, Critchley, & 
Capewell, 2003).  
73 
 
The main strength of this study is its simplicity using available data to evaluate the 
relationship between TF, SFA and associated factors with CHD. Whereas observational 
studies such as Kushi et al (1985) assessed individuals diet at baseline without follow 
up in a twenty year study the strength of this study is it looks at continued intakes and 
although data used is at a population not individual level it would be expected that the 
relationship still be valid and potentially more appropriate when evaluating population 
guidelines.  
Conclusion 
The results of this study support current population dietary guidelines to reduce SFA 
and TF show differences in regions and countries and the differences in intake over 
time compared to the CHD question the association between SFA, TF and CHD. It is 
clear further research is needed and it would be recommend dietary guidelines 
updated in light of continued non adherence and continued decline of CHD in the UK. 
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